Cargando…

Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma

Galanin is a 30 amino acid peptide that stimulates three subtype receptors (GAL(1–3)R). M89b is a lanthionine-stabilized, C-terminally truncated galanin analog that specifically stimulates GAL(2)R. We investigated the potential of M89b as a therapeutic for pancreatic ductal adenocarcinoma (PDAC) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namsolleck, Pawel, Kofler, Barbara, Moll, Gert N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299363/ https://www.ncbi.nlm.nih.gov/pubmed/37373336 http://dx.doi.org/10.3390/ijms241210193

Ejemplares similares

Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures
por: Drexel, Meinrad, et al.
Publicado: (2018)

Intranasal Delivery of a Methyllanthionine-Stabilized Galanin Receptor-2-Selective Agonist Reduces Acute Food Intake
por: Kuipers, Anneke, et al.
Publicado: (2021)

Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?
por: Namsolleck, Pawel, et al.
Publicado: (2020)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Galanin Receptors as Drug Target for Novel Antidepressants: Review
por: Demsie, Desalegn Getnet, et al.
Publicado: (2020)

Contribution of the galanin system to inflammation
por: Kofler, Barbara, et al.
Publicado: (2015)

Lack of Galanin 3 Receptor Aggravates Murine Autoimmune Arthritis
por: Botz, Bálint, et al.
Publicado: (2016)

Galanin System in Human Glioma and Pituitary Adenoma
por: Falkenstetter, Sarah, et al.
Publicado: (2020)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

Galanin Receptors and Ligands
por: Webling, Kristin E. B., et al.
Publicado: (2012)

Galanin receptor ligands
por: Langel, Ülo
Publicado: (2015)

Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status
por: Perel, Y, et al.
Publicado: (2002)

Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors
por: Moll, Gert N., et al.
Publicado: (2020)

Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma
por: Huber, Sara, et al.
Publicado: (2023)

Influence of the regulatory peptide galanin on cytokine expression in human monocytes
por: Ramspacher, Andrea, et al.
Publicado: (2019)

Involvement of Neuropeptide Galanin Receptors 2 and 3 in Learning, Memory and Anxiety in Aging Mice
por: Locker, Felix, et al.
Publicado: (2021)

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
por: Li, Q., et al.
Publicado: (2020)

Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma
por: Fischietti, Mariafausta, et al.
Publicado: (2021)

Peripheral Galanin Receptor 2 as a Target for the Modulation of Pain
por: Hulse, Richard P., et al.
Publicado: (2012)

Galanin is a potent modulator of cytokine and chemokine expression in human macrophages
por: Koller, Andreas, et al.
Publicado: (2019)

Thermoregulatory effect of alarin, a new member of the galanin peptide family
por: Mikó, Alexandra, et al.
Publicado: (2014)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021)

Cell-to-cell interaction analysis of prognostic ligand-receptor pairs in human pancreatic ductal adenocarcinoma
por: Suzuki, Sayaka R., et al.
Publicado: (2021)

Three dimensional modeling of N-terminal region of galanin and its interaction with the galanin receptor
por: Parthiban, Marimuthu, et al.
Publicado: (2007)

A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma
por: Hung, Jessica, et al.
Publicado: (2023)

Structural insights into galanin receptor signaling
por: Jiang, Wentong, et al.
Publicado: (2022)

Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis
por: Arundhathi, Arivajiagane, et al.
Publicado: (2016)

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
por: Clawson, Gary A., et al.
Publicado: (2017)

Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma
por: Song, Hai-Yan, et al.
Publicado: (2018)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
por: Kelly, Kimberly A, et al.
Publicado: (2008)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma
por: Wang, Jiatong, et al.
Publicado: (2023)

Involvement of galanin and galanin receptor 1 in nociceptive modulation in the central nucleus of amygdala in normal and neuropathic rats
por: Li, Shi-Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vh4qopr10hg482d7q42q6u1uva